Liver-Specific Regulatory Element for Stable High Gene Expression
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing liver gene therapy methods face challenges in achieving high-efficiency and stable expression of genes of interest due to low transcriptional activity and cell type specificity, which limits the therapeutic potential.
Innovation Solution
An isolated nucleic acid molecule containing a liver-specific expression regulatory element, comprising promoters derived from dog serpinAl, Xenopus laevis vitellogenin A2, and Xenopus laevis albumin genes, enhances gene expression in liver cells by up to 500% compared to conventional promoters, unaffected by introns or polyadenylation signals.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional promoters are used for gene expression in liver cells, then the gene expression can be achieved, but the expression level remains low due to weak transcriptional activity
Solution Approach 1:
The patent combines multiple liver-specific promoter elements (serpinAl promoter, vitellogenin promoter, albumin promoter) into a single composite regulatory element. This merging of multiple functional promoter components creates a synergistic effect that dramatically enhances transcriptional activity and gene expression levels in liver cells, resolving the contradiction between achieving expression and maintaining high transcriptional activity.
Solution Approach 2:
The invention creates a composite regulatory element by integrating multiple promoter sequences from different liver-specific genes. This composite structure functions as a enhanced transcriptional unit that leverages the strengths of each individual promoter element, achieving high-level and stable gene expression in hepatocytes that surpasses conventional single promoters.
2Productivity
If regulatory elements are added to promote gene expression, then expression level increases, but the complexity of the nucleic acid construct increases
Solution Approach 1:
The composite liver-specific regulatory element serves multiple functions simultaneously: it provides tissue-specific expression (liver hepatocytes), achieves high transcriptional activity, ensures stable long-term expression, and maintains compatibility with different gene sequences. This multi-functionality in a single element reduces the need for multiple separate regulatory components, thereby managing complexity while maximizing expression efficiency.
3Productivity
If liver-specific regulatory elements are used to enhance gene expression, then expression level increases by up to 500%, but the specificity requirement for liver cells reduces flexibility in application
Solution Approach 1:
The patent applies local quality by designing a regulatory element with intrinsic liver-specificity through the selection of liver-enriched promoter sequences (serpinAl, vitellogenin, albumin). These sequences contain specific transcription factor binding sites that are naturally active in hepatocytes, providing localized control of gene expression precisely where needed in the liver while maintaining high expression levels.
Data Source
AI summary
A liver-specific expressional regulatory element, including, in order from 51 to 31: a promoter of a dog serpinAl gene or a functional fragment thereof, a promoter of a Xenopus laevis vitellogenin A2 gene or a functional fragment thereof, a promoter of a Xenopus laevis albumin gene or a functional fragment thereof, and a promoter of a human serpinAl gene or a functional fragment thereof.